How much funding has HiFiBio raised?

HiFiBio has raised $179.5M in total funding, most recently a series d round.

Who are HiFiBio's investors?

HiFiBio's investors include Mirae Asset Financial Group, Kite Ventures, Sequoia Capital, LYFE Capital.

Where is HiFiBio headquartered?

HiFiBio is headquartered in Cambridge.

What industry is HiFiBio in?

HiFiBio operates in Biotech, Healthcare.

HiFiBio

Home - HiFiBiO Therapeutics

Cambridge · Founded 2013 · $179.5M raised

Biotech

Healthcare

Headquarters: Cambridge
Employees: 51–200
Founded: 2013
Business Model: B2B

Website: hifibio.com
Total Funding: $179.5M
Last Round: $75.0M Series DJun 2021
Rounds: 3

About

HiFiBiO Therapeutics is a multinational biotherapeutics company that integrates single-cell profiling technologies with deep biological expertise to discover and advance antibody drugs for cancer and autoimmune disorders. The company operates facilities across Cambridge, Massachusetts, Paris, France, and Hangzhou, China, pursuing curative immunotherapies for patients with high unmet medical needs.

Summary

HiFiBio is a Biotech company based in Cambridge, founded in 2013. It has raised $179.5M in total across 3 rounds, most recently a $75.0M Series D round in Jun 2021. Investors include Mirae Asset Financial Group, Kite Ventures and Sequoia Capital.

LinkedIn X (Twitter)